The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis

The multiple sclerosis (MS) incidence rate has been increasing in Russia, but the information about the gut bacteriobiome in the MS-afflicted patients is scarce. Using the Illumina MiSeq sequencing of 16S rRNA gene amplicons, we aimed to analyze the <i>Firmicutes</i> phylum and its taxa...

Full description

Bibliographic Details
Main Authors: Madina Kozhieva, Natalia Naumova, Tatiana Alikina, Alexey Boyko, Valentin Vlassov, Marsel R. Kabilov
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/11/1/55
_version_ 1797411632323756032
author Madina Kozhieva
Natalia Naumova
Tatiana Alikina
Alexey Boyko
Valentin Vlassov
Marsel R. Kabilov
author_facet Madina Kozhieva
Natalia Naumova
Tatiana Alikina
Alexey Boyko
Valentin Vlassov
Marsel R. Kabilov
author_sort Madina Kozhieva
collection DOAJ
description The multiple sclerosis (MS) incidence rate has been increasing in Russia, but the information about the gut bacteriobiome in the MS-afflicted patients is scarce. Using the Illumina MiSeq sequencing of 16S rRNA gene amplicons, we aimed to analyze the <i>Firmicutes</i> phylum and its taxa in a cohort of Moscow patients with relapsing-remitting MS, assessing the effects of age, BMI, disease modifying therapy (DMT), disability (EDSS), and gender. Among 1252 identified bacterial OTUs, 857 represented Firmicutes. The phylum was the most abundant also in sequence reads, overall averaging 74 ± 13%. The general linear model (GLM) analysis implicated <i>Firmicutes/Clostridia/Clostridiales/Lachospiraceae/Blautia/Blautia wexlerae</i> as increasing with BMI, and only <i>Lachospiraceae/Blautia/Blautia wexlerae</i> as increasing with age. A marked DMT-related decrease in <i>Firmicutes</i> was observed in females at the phylum, class (<i>Clostridia</i>), and order (<i>Clostridiales</i>) levels. The results of our study implicate DMT and gender as factors shaping the fecal <i>Firmicutes</i> assemblages. Together with the gender-dependent differential MS incidence growth rate in the country, the results suggest the likely involvement of gender-specific pathoecological mechanisms underlying the occurrence of the disease, switching between its phenotypes and response to disease-modifying therapies. Overall, the presented profile of <i>Firmicutes</i> can be used as a reference for more detailed research aimed at elucidating the contribution of this core phylum and its lower taxa into the etiology and progression of relapsing-remitting multiple sclerosis.
first_indexed 2024-03-09T04:48:56Z
format Article
id doaj.art-813366b2d2e747dfb3b0ad04ccbbcca5
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T04:48:56Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-813366b2d2e747dfb3b0ad04ccbbcca52023-12-03T13:12:15ZengMDPI AGLife2075-17292021-01-011115510.3390/life11010055The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple SclerosisMadina Kozhieva0Natalia Naumova1Tatiana Alikina2Alexey Boyko3Valentin Vlassov4Marsel R. Kabilov5Department of Neurology, Neurosurgery and Medical Genetics of the Pirogov Medical University, 117513 Moscow, RussiaInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, RussiaDepartment of Neuroimmunology of the Federal Center of CVPI, 117513 Moscow, RussiaInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, RussiaThe multiple sclerosis (MS) incidence rate has been increasing in Russia, but the information about the gut bacteriobiome in the MS-afflicted patients is scarce. Using the Illumina MiSeq sequencing of 16S rRNA gene amplicons, we aimed to analyze the <i>Firmicutes</i> phylum and its taxa in a cohort of Moscow patients with relapsing-remitting MS, assessing the effects of age, BMI, disease modifying therapy (DMT), disability (EDSS), and gender. Among 1252 identified bacterial OTUs, 857 represented Firmicutes. The phylum was the most abundant also in sequence reads, overall averaging 74 ± 13%. The general linear model (GLM) analysis implicated <i>Firmicutes/Clostridia/Clostridiales/Lachospiraceae/Blautia/Blautia wexlerae</i> as increasing with BMI, and only <i>Lachospiraceae/Blautia/Blautia wexlerae</i> as increasing with age. A marked DMT-related decrease in <i>Firmicutes</i> was observed in females at the phylum, class (<i>Clostridia</i>), and order (<i>Clostridiales</i>) levels. The results of our study implicate DMT and gender as factors shaping the fecal <i>Firmicutes</i> assemblages. Together with the gender-dependent differential MS incidence growth rate in the country, the results suggest the likely involvement of gender-specific pathoecological mechanisms underlying the occurrence of the disease, switching between its phenotypes and response to disease-modifying therapies. Overall, the presented profile of <i>Firmicutes</i> can be used as a reference for more detailed research aimed at elucidating the contribution of this core phylum and its lower taxa into the etiology and progression of relapsing-remitting multiple sclerosis.https://www.mdpi.com/2075-1729/11/1/55multiple sclerosisrelapsing-remitting coursefecal bacteriobiome16S rRNA gene amplicon sequencing
spellingShingle Madina Kozhieva
Natalia Naumova
Tatiana Alikina
Alexey Boyko
Valentin Vlassov
Marsel R. Kabilov
The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis
Life
multiple sclerosis
relapsing-remitting course
fecal bacteriobiome
16S rRNA gene amplicon sequencing
title The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis
title_full The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis
title_fullStr The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis
title_full_unstemmed The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis
title_short The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple Sclerosis
title_sort core of gut life i firmicutes i profile in patients with relapsing remitting multiple sclerosis
topic multiple sclerosis
relapsing-remitting course
fecal bacteriobiome
16S rRNA gene amplicon sequencing
url https://www.mdpi.com/2075-1729/11/1/55
work_keys_str_mv AT madinakozhieva thecoreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT natalianaumova thecoreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT tatianaalikina thecoreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT alexeyboyko thecoreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT valentinvlassov thecoreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT marselrkabilov thecoreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT madinakozhieva coreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT natalianaumova coreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT tatianaalikina coreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT alexeyboyko coreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT valentinvlassov coreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis
AT marselrkabilov coreofgutlifeifirmicutesiprofileinpatientswithrelapsingremittingmultiplesclerosis